New 52 Week High Today

Natera Inc NTRA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/24/24 EDT
109.51UNCH (UNCH)
Volume
71,527
Close
109.51UNCH (UNCH)
Volume
580,686
52 week range
36.90 - 110.09
Loading...
  • Open108.40
  • Day High110.09
  • Day Low107.41
  • Prev Close107.51
  • 52 Week High110.09
  • 52 Week High Date05/22/24
  • 52 Week Low36.90
  • 52 Week Low Date10/30/23

Key Stats

  • Market Cap13.448B
  • Shares Out122.80M
  • 10 Day Average Volume1.29M
  • Dividend-
  • Dividend Yield-
  • Beta1.52
  • YTD % Change74.82

KEY STATS

  • Open108.40
  • Day High110.09
  • Day Low107.41
  • Prev Close107.51
  • 52 Week High110.09
  • 52 Week High Date05/22/24
  • 52 Week Low36.90
  • 52 Week Low Date10/30/23
  • Market Cap13.448B
  • Shares Out122.80M
  • 10 Day Average Volume1.29M
  • Dividend-
  • Dividend Yield-
  • Beta1.52
  • YTD % Change74.82

RATIOS/PROFITABILITY

  • EPS (TTM)-3.13
  • P/E (TTM)-34.93
  • Fwd P/E (NTM)-41.65
  • EBITDA (TTM)-356.175M
  • ROE (TTM)-50.59%
  • Revenue (TTM)1.209B
  • Gross Margin (TTM)50.28%
  • Net Margin (TTM)-30.24%
  • Debt To Equity (MRQ)45.80%

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Natera, Inc. is a diagnostics company, which is focused on the development and commercialization of molecular testing services, applying its technology in the fields of women’s health, oncology and organ health. Its cell-free deoxyribonucleic acid (cfDNA) technology combines its molecular assays, which reliably measure many informative regions across the genome from samples as small as a single cell. The Company's product offerings include Panorama Non-Invasive Prenatal Test...
Matthew Rabinowitz Ph.D.
Executive Chairman of the Board, Co-Founder
Steven Chapman
Chief Executive Officer, Director
John Fesko
President, Chief Business Officer
Michael Brophy
Chief Financial Officer
Address
13011 MCCALLEN PASS
BUILDING A SUITE 100
Austin, TX
78753
United States

Top Peers

SYMBOLLASTCHG%CHG
SRPT
Sarepta Therapeutics Inc
123.46UNCHUNCH
MEDP
Medpace Holdings Inc
390.55UNCHUNCH
NBIX
Neurocrine Biosciences Inc
139.40UNCHUNCH
HALO
Halozyme Therapeutics Inc
43.82UNCHUNCH
ROIV
Roivant Sciences Ltd
10.98UNCHUNCH